Do the Russians Always Cheat? Milton Packer provides a perspective on the meaning of truth in medicine and in life. Dec 13, 2017
Can Industry-Funded Research Be Trusted? Milton Packer wonders who is really trustworthy Dec 06, 2017
Survival Not Better When Patients Have ICD Plus Newer LVAD Combo may even be associated with harm, registry suggests Nov 29, 2017
Move to Get Benicar Off Market; Nexterone Recall; Squirrel Hibernation Stroke Tx? Recent developments of interest in cardiovascular medicine Nov 20, 2017
AHA: For CIED Surgery, NOAC Administration Up to Clinician Continued or interrupted therapy carried same risk of clinically significant hematoma development Nov 12, 2017
Who Actually Is Reviewing All Those Preauthorization Requests? Milton Packer thinks you should know how the system works Nov 08, 2017
Borderline Pulmonary Hypertension Tied to Mortality Risk Small increases in pressure might signal left heart failure, not early PAH Oct 25, 2017
Supplements Affect NT-ProBNP; Cord Stem Cells; ED Exit Sans Stress Test Cardiovascular Daily wraps up the top cardiology news of the week Sep 29, 2017
Entresto Boosts Sex in HF; Venom Antidote to Xa Drugs; Guilty Plea for FH Vagueness Recent developments of interest in cardiovascular medicine Sep 25, 2017
HF Monitor Trips on PA Injury in Postmarket Surveillance Reintervention or device recalibration often needed after PA injury Sep 18, 2017
TTR Cardiomyopathy Easily Detected By Biceps Bunching Biceps tendon rupture may be a clue to HF cause Sep 12, 2017
ESC: Merck REVEALS a Slightly Positive CETP Inhibitor Trial A CETP inhibitor scores after 3 strikes for the class Aug 29, 2017
Inflammation, Secondary Prevention, Diet in Spotlight at ESC CANTOS, COMPASS, PURE will headline the world's largest cardiology meeting Aug 24, 2017
Guidance Issued on PET Imaging in Diagnosing Cardiac Sarcoidosis ASNC, SNMMI release recommendations for difficult diagnostic challenge Aug 19, 2017
Studies Stop Short of Quelling TAVR Durability Fears Structural valve deterioration observed in 3.9% over 5 years May 20, 2017
Does Longer TAVR Time Make Stroke More Likely? SURTAVI neuro substudy bolsters comparability between TAVR, SAVR May 19, 2017
Lotus TAVR Device Again Trips Up on Pacemaker Rate Otherwise, efficacy superior overall against CoreValve in REPRISE III trial May 17, 2017
Lower BP Targeted in New Heart Failure Guidelines ACC/AHA/HFSA recommend adjusted SPRINT target of May 02, 2017
CardioBrief: Serious Questions Raised About Validity Of International Trials TOPCAT analysis is the 'smoking gun' for trouble from 'offshoring' trials Apr 26, 2017
Dosing Crucial for Digoxin, Warfarin Safety Digoxin unsafe at high levels regardless of heart failure Mar 21, 2017
SURTAVI: TAVR Matches Surgery in Lowest-Risk Cohort But reinterventions, parvalvular regurgitation, and pacemaker implants mar a supposed victory Mar 17, 2017
Everyday Exposure to EM Fields Can Disrupt Pacemakers Lower sensitivity and bipolar sensing recommended Feb 27, 2017
Wise Buy? Left Ventricular Assist Devices Getting better and cheaper, but 'nobody wears pink ribbons for heart failure' Feb 21, 2017
Subclavian TAVR Safe When Femoral Access Is Risky Trial analysis shows similar morbidity, mortality Jan 24, 2017
SAVR Beats Expectations in Intermediate Risk Trial Lower mortality than surgical risk score predicted in PARTNER 2A Jan 24, 2017
Novartis Pulls Out of Controversial Entresto Contest Cardiologists named to review panel had quit Dec 19, 2016
CMS to Offer Billing Code for Heart Failure Specialists Should eliminate denials for appearance of double-billing Dec 02, 2016
Trial: No Benefit for High-Dose Diuretic in Acute HF But phase II results might not be the final word Nov 17, 2016
AHA: No Pump Thrombosis With Next-Gen LVAD? Better outcomes in HeartMate 3 trial hinged on fewer malfunctions Nov 16, 2016
AHA: Real World TAVR Is All About Patient Selection Intermediate risk is a moving target Nov 15, 2016
AHA: Long-Term Benefit in HF Patients Elusive for Novel Vasodilator Investigational drug ularitide had no effect on mortality or clinical outcomes Nov 13, 2016
TCT: TAVR Holds Up Pretty Well Over Time Also, 2-year data confirm lasting improvements in QoL Nov 02, 2016
TCT: Embolic Protection Flops for TAVR New brain lesions or clinical strokes unaffected in SENTINEL trial Nov 01, 2016
CardioBrief: Impella No Better Than IABP in Cardiogenic Shock Underpowered IMPRESS trial shows no mortality benefit Oct 30, 2016
HFSA: Clinical Benefits Tied To Lung Monitoring Persist HF rehospitalization, deaths remain reduced up to 4.5 years Sep 21, 2016
HFSA: Treat to NT-proBNP Target Flops in Trial Outcomes no better with treatment aimed at 30% reduction Sep 20, 2016
HFSA: Did LAP Monitoring Cut HF Rehospitalizations? LAPTOP-HF investigators tried to make sense of terminated study Sep 19, 2016
